What does Lipocine, Inc. do?

Jun 22 2025 06:51 PM IST
share
Share Via
Lipocine, Inc. is a clinical-stage biopharmaceutical company specializing in oral drug delivery technologies. As of March 2025, it has a market cap of $16.79 million, with net sales of $0 million and a net loss of $2 million.
Overview:
Lipocine, Inc. is a clinical-stage biopharmaceutical company focused on developing oral drug delivery technologies for pharmaceutical products within the Pharmaceuticals & Biotechnology industry, categorized as a micro-cap company.

Financial Snapshot:
Most recent Net Sales: 0 Million (Quarterly Results - Mar 2025)
Most recent Net Profit: -2 Million (Quarterly Results - Mar 2025)
Market-cap: USD 16.79 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -1.03
Return on Equity: -28.27%
Price to Book: 0.87

Contact Details:
Address: 675 S Arapeen Dr Ste 202, SALT LAKE CITY UT: 84108-1295
Tel: 1 801 9947383
Fax: 1 801 9947388
Website: https://www.lipocine.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Lipocine, Inc. Stock Plummets to New 52-Week Low of $2.57
Oct 31 2025 04:24 PM IST
share
Share Via
Lipocine, Inc. Stock Plummets to New 52-Week Low of $2.65
Sep 26 2025 03:14 PM IST
share
Share Via
Is Lipocine, Inc. technically bullish or bearish?
Sep 20 2025 07:54 PM IST
share
Share Via
Is Lipocine, Inc. overvalued or undervalued?
Sep 20 2025 06:28 PM IST
share
Share Via
Is Lipocine, Inc. overvalued or undervalued?
Jun 25 2025 09:07 AM IST
share
Share Via
Most Read
Why is Bluestone Jewel falling/rising?
1 hour ago
share
Share Via
Why is Borana Weaves falling/rising?
1 hour ago
share
Share Via
Why is Malpani Pipes falling/rising?
1 hour ago
share
Share Via
Why is Sat Kartar falling/rising?
1 hour ago
share
Share Via
Why is Baazar Style falling/rising?
1 hour ago
share
Share Via
Why is Blackbuck falling/rising?
1 hour ago
share
Share Via